Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000357799

Medchemexpress LLC Crizotinib (hydrochloride) | 1415560-69-8 | 99.7% | C21H23Cl3FN5O | 1 ML
SDP

Catalog No. 5000357799
Encompass_Preferred

Crizotinib hydrochloride is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor. It inhibits tyrosine phosphorylation of NPM-ALK and c-Met in cell-based assays and is also a ROS proto-oncogene 1 (ROS1) inhibitor, demonstrating effective tumor growth inhibition.

  • Orally bioavailable
  • Selective ALK and c-Met inhibitor
  • Inhibits tyrosine phosphorylation of NPM-ALK and c-Met
  • Functions as a ROS proto-oncogene 1 (ROS1) inhibitor
  • Demonstrates effective tumor growth inhibition

Catalog No. 50-003-57799 Supplier Medchemexpress LLC Supplier No. HY50878A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Crizotinib hydrochloride is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor. It inhibits tyrosine phosphorylation of NPM-ALK and c-Met in cell-based assays and is also a ROS proto-oncogene 1 (ROS1) inhibitor, demonstrating effective tumor growth inhibition.

  • Orally bioavailable
  • Selective ALK and c-Met inhibitor
  • Inhibits tyrosine phosphorylation of NPM-ALK and c-Met
  • Functions as a ROS proto-oncogene 1 (ROS1) inhibitor
  • Demonstrates effective tumor growth inhibition

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.